(Q42006227)

15 October 2017

Effect of ICI 118551 on bronchial beta-adrenoceptor function and exercise heart rate in normal man. (English)

1 reference

15 October 2017

A E Tattersfield

1

1 reference

15 October 2017

D J Cragg

series ordinal

2

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 December 1983

1 reference

British Journal of Clinical Pharmacology

15 October 2017

1 reference

15 October 2017

16

1 reference

15 October 2017

6

1 reference

15 October 2017

587-590

1 reference

Quantitative assessment of bronchial beta-adrenoceptor blockade in man

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428330

PubMed Central

reference URL

Evidence that ICI 118, 551 is a potent, highly Beta 2-selective adrenoceptor antagonist and can be used to characterize Beta-adrenoceptor populations in tissues.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428330

PubMed Central

reference URL

Assessment of bronchial beta blockade after oral bevantolol

16 June 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/6140938

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1983.TB02226.X

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

6140938

1 reference